» Articles » PMID: 24428376

Human Mesenchymal Stromal Cells from Adult and Neonatal Sources: a Comparative in Vitro Analysis of Their Immunosuppressive Properties Against T Cells

Overview
Journal Stem Cells Dev
Date 2014 Jan 17
PMID 24428376
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Bone marrow-mesenchymal stromal cells (BM-MSCs) have immunosuppressive properties and have been used in cell therapies as immune regulators for the treatment of graft-versus-host disease. We have previously characterized several biological properties of MSCs from placenta (PL) and umbilical cord blood (UCB), and compared them to those of BM-the gold standard. In the present study, we have compared MSCs from BM, UCB, and PL in terms of their immunosuppressive properties against lymphoid cell populations enriched for CD3(+) T cells. Our results confirm the immunosuppressive potential of BM-MSCs, and demonstrate that MSCs from UCB and, to a lesser extent PL, also have immunosuppressive potential. In contrast to PL-MSCs, BM-MSCs and UCB-MSCs significantly inhibited the proliferation of both CD4(+) and CD8(+) activated T cells in a cell-cell contact-dependent manner. Such a reduced proliferation in cell cocultures correlated with upregulation of programmed death ligand 1 on MSCs and cytotoxic T lymphocyte-associated Ag-4 (CTLA-4) on T cells, and increased production of interferon-γ, interleukin-10, and prostaglandin E2. Importantly, and in contrast to PL-MSCs, both BM-MSCs and UCB-MSCs favored the generation of T-cell subsets displaying a regulatory phenotype CD4(+)CD25(+)CTLA-4(+). Our results indicate that, besides BM-MSCs, UCB-MSCs might be a potent and reliable candidate for future therapeutic applications.

Citing Articles

Mesenchymal Stem/Stromal Cells Derived from Dental Tissues Mediate the Immunoregulation of T Cells through the Purinergic Pathway.

Poblano-Perez L, Monroy-Garcia A, Fragoso-Gonzalez G, Mora-Garcia M, Castell-Rodriguez A, Mayani H Int J Mol Sci. 2024; 25(17).

PMID: 39273524 PMC: 11395442. DOI: 10.3390/ijms25179578.


Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model.

Chen Z, Yang C, Ji J, Chen M, Han B Stem Cells Int. 2024; 2024:4095268.

PMID: 39161367 PMC: 11333133. DOI: 10.1155/2024/4095268.


Mesenchymal Stromal Cells Derived from Dental Tissues: Immunomodulatory Properties and Clinical Potential.

Poblano-Perez L, Castro-Manrreza M, Gonzalez-Alva P, Fajardo-Orduna G, Montesinos J Int J Mol Sci. 2024; 25(4).

PMID: 38396665 PMC: 10888494. DOI: 10.3390/ijms25041986.


Enhancing Immunomodulatory Function of Mesenchymal Stromal Cells by Hydrogel Encapsulation.

Cheng H, Anggelia M, Liu S, Lin C, Lin C Cells. 2024; 13(3.

PMID: 38334602 PMC: 10854565. DOI: 10.3390/cells13030210.


Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery.

Couto P, Al-Arawe N, Filgueiras I, Fonseca D, Hinterseher I, Catar R Front Immunol. 2023; 14:1200180.

PMID: 37415976 PMC: 10321603. DOI: 10.3389/fimmu.2023.1200180.


References
1.
Kronsteiner B, Wolbank S, Peterbauer A, Hackl C, Redl H, van Griensven M . Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. Stem Cells Dev. 2011; 20(12):2115-26. DOI: 10.1089/scd.2011.0031. View

2.
Chang C, Yen M, Chen Y, Chien C, Huang H, Bai C . Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells. 2006; 24(11):2466-77. DOI: 10.1634/stemcells.2006-0071. View

3.
Le Blanc K, Rasmusson I, Gotherstrom C, Seidel C, Sundberg B, Sundin M . Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol. 2004; 60(3):307-15. DOI: 10.1111/j.0300-9475.2004.01483.x. View

4.
Ryan J, Barry F, Murphy J, Mahon B . Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol. 2007; 149(2):353-63. PMC: 1941956. DOI: 10.1111/j.1365-2249.2007.03422.x. View

5.
Boasso A, Herbeuval J, Hardy A, Winkler C, Shearer G . Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells. Blood. 2004; 105(4):1574-81. DOI: 10.1182/blood-2004-06-2089. View